We are live on
!
Find out more
AA
ALPS Advisors Portfolio holdings
AUM
$21.3B
1-Year Est. Return
21.71%
This Fund
S&P 500
This Quarter
Est. Return
+13.09%
1 Year Est. Return
+21.71%
3 Year Est. Return
+77.63%
5 Year Est. Return
+121.1%
10 Year Est. Return
+198.29%
AUM
$11.3B
AUM Growth
+$1.07B
(+10%)
Cap. Flow
-$113M
Cap. Flow
% of AUM
-1%
Top 10 Holdings %
Top 10 Hldgs %
43.92%
Holding
930
New
74
Increased
169
Reduced
352
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enterprise Products Partners
EPD
|
+$37.6M |
| 2 |
ChargePoint
CHPT
|
+$32.5M |
| 3 |
JNPR
Juniper Networks
JNPR
|
+$23.3M |
| 4 |
CEQP
Crestwood Equity Partners LP
CEQP
|
+$23M |
| 5 |
Shoals Technologies Group
SHLS
|
+$21.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Energy Transfer Partners
ET
|
+$77.7M |
| 2 |
NBLX
Noble Midstream Partners LP
NBLX
|
+$65.5M |
| 3 |
Plains All American Pipeline
PAA
|
+$49.7M |
| 4 |
Xerox
XRX
|
+$20.9M |
| 5 |
Acuity Brands
AYI
|
+$20M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 52.67% |
| 2 | Financials | 10.26% |
| 3 | Technology | 6.92% |
| 4 | Healthcare | 4.76% |
| 5 | Consumer Discretionary | 3.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Motorola Solutions
MSI
$69.4B
| $1.28M | 0.01% |
5,900
-306
| -5% | -$61.1K |
|
377
Mercury Insurance
MCY
$5.94B
| $1.28M | 0.01% |
19,659
-902
| -4% | -$57.2K |
|
|
CPRX
378
DELISTED
Catalyst Pharmaceutical
CPRX
| $1.25M | 0.01% |
217,878
-51,382
| -19% | -$265K |
|
|
CCXI
379
DELISTED
ChemoCentryx, Inc.
CCXI
| $1.23M | 0.01% |
91,864
-34,078
| -27% | -$840K |
|
380
Artisan Partners
APAM
$2.79B
| $1.23M | 0.01% |
24,182
-915
| -4% | -$48.1K |
|
381
Orion Energy Systems
OESX
$41.1M
| $1.23M | 0.01% |
21,453
-3,822
| -15% | -$232K |
|
382
LXP Industrial Trust
LXP
$3.53B
| $1.23M | 0.01% |
20,529
-913
| -4% | -$55.6K |
|
|
GTHX
383
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $1.22M | 0.01% |
+55,417
| New | +$1.23M |
|
384
Entergy
ETR
$54.1B
| $1.18M | 0.01% |
23,742
-1,102
| -4% | -$58.1K |
|
385
Arcturus Therapeutics
ARCT
$157M
| $1.17M | 0.01% |
+34,665
| New | +$1.17M |
|
386
Enanta Pharmaceuticals
ENTA
$372M
| $1.17M | 0.01% |
26,597
-9,727
| -27% | -$476K |
|
387
CubeSmart
CUBE
$9.53B
| $1.16M | 0.01% |
25,094
-2,335
| -9% | -$101K |
|
388
Travere Therapeutics
TVTX
$5.33B
| $1.16M | 0.01% |
79,625
-29,350
| -27% | -$579K |
|
|
AKRO
389
DELISTED
Akero Therapeutics
AKRO
| $1.14M | 0.01% |
45,872
-16,942
| -27% | -$476K |
|
|
RDUS
390
DELISTED
Radius Health, Inc.
RDUS
| $1.14M | 0.01% |
62,224
-22,614
| -27% | -$450K |
|
391
Annexon
ANNX
$855M
| $1.13M | 0.01% |
+50,389
| New | +$1.12M |
|
|
ALXN
392
DELISTED
Alexion Pharmaceuticals
ALXN
| $1.12M | 0.01% |
6,087
-139
| -2% | -$23.9K |
|
393
Zebra Technologies
ZBRA
$12.4B
| $1.12M | 0.01% |
2,108
-50
| -2% | -$24.9K |
|
394
VICI Properties
VICI
$29.4B
| $1.11M | 0.01% |
35,933
-1,312
| -4% | -$40.7K |
|
395
Syndax Pharmaceuticals
SNDX
$1.84B
| $1.09M | 0.01% |
+63,541
| New | +$1.16M |
|
396
Dollar General
DG
$25.9B
| $1.07M | 0.01% |
4,959
-168
| -3% | -$35.3K |
|
397
EPAM Systems
EPAM
$4.69B
| $1.07M | 0.01% |
2,099
-42
| -2% | -$19.7K |
|
398
Praxis Precision Medicines
PRAX
$9.07B
| $1.05M | 0.01% |
+3,830
| New | +$1.37M |
|
|
RAPT
399
DELISTED
RAPT Therapeutics
RAPT
| $1.05M | 0.01% |
+4,117
| New | +$769K |
|
400
Xenon Pharmaceuticals
XENE
$6.32B
| $1M | 0.01% |
53,959
-9,372
| -15% | -$173K |
|
Similar funds
PAG
MMH
IC
DSA
VARA
SC
CB
ALPS Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, ALPS Advisors held 930 positions worth $11.3B, up 10% from $10.2B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
ALPS Advisors's Q2 2021 filing shows 74 new, 169 increased, 352 reduced and 28 closed positions. Its largest new stake was ChargePoint: 61,396 shares worth $42.7M. The largest sale was Energy Transfer Partners, an estimated $77.7M.
By sector, the portfolio is most concentrated in Energy at 53% of assets, up from 50% a quarter earlier, followed by Financials and Technology.
- ALPS Advisors's largest Q2 2021 buy was ChargePoint: 61,396 shares worth $42.7M.
- ALPS Advisors added most to Enterprise Products Partners in Q2 2021, an estimated $37.6M increase.
- ALPS Advisors's biggest Q2 2021 reduction was Energy Transfer Partners, cutting an estimated $77.7M.
- ALPS Advisors fully exited Noble Midstream Partners LP in Q2 2021, selling an estimated $65.5M.
- ALPS Advisors's ten largest holdings make up 44% of its $11.3B portfolio in Q2 2021.
- ALPS Advisors opened 74 new positions and closed 28 in Q2 2021.
- ALPS Advisors's portfolio value rose 10% quarter-over-quarter to $11.3B.
Based on ALPS Advisors's 13F filing for Q2 2021, filed 11 Aug 2021.